Hamad medical corporation
Doha, 3050, Qatar
NCT Number: NCT02494219
Comparison of Immunochromatographic Test for rapid detection of group A streptococcal antigen with culture in Pediatric patients.
Looking for future studies?
Notify Me1 year–14 year
All sexes
Interventional
Not applicable
Doha, 3050, Qatar
Throat swabbing by two port germ Amines agar (copan) swabs,then the swabs were randomly labeled as swab A and swab B.Swab A was processed for rapid streptococcal test and swab B was processed for culture in Colombia blood agar.All patients were followed up after 48-72 hours with the final culture results that ultimately determined the need to continue or discontinue treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Throat swab obtained for rapid strep test in addition to throat culture,in order to check the accuracy of Rapid Immunochromatographic streptococcal test in detection of streptococcal pharyngitis
Time frame: upto 48 hours
Time frame: upto 48hours
Hamad Medical Corporation
Industry
Comparison of Immunochromatographic Test for Rapid Detection of Group A Streptococcal Antigen With Culture in Pediatric Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03237299
Infections, Otorhinolaryngologic Diseases
Paris, France
View Trial DetailsNCT05127161
Acute Respiratory Tract Infection, Acute Sinusitis
Plantation, Florida, United States
View Trial DetailsNCT06027593
Acute Otitis Media, Community-Acquired Infections
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06005337
Acute Asthma, Acute Otitis Media
Edmonton, Alberta, Canada
View Trial Details